Previous 10 | Next 10 |
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Markets love resolution and COVID-19 vaccine successes en...
Distillate Capital Partners was formed in 2017 and is based in Chicago, IL. The fund strategies use cash-flow-based measures of value and quality that are designed to avoid accounting distortions that we believe have rendered many traditional metrics less relevant in an increasingly asset...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The Q4 earnings season cranks up with Procter & Gamble (NYSE:PG), Netflix (NASDAQ:NFLX) and Intel (NASDAQ:INTC) some...
The Q4 earnings season cranks up with Procter & Gamble (PG), Netflix (NFLX) and Intel (INTC) some of the more intriguing names to spill numbers. It is week two of trading for Poshmark (POSH) and Petco (WOOF) after huge first day gains were pared a bit on Friday. The economic calendar brin...
Viatris (VTRS) has lost 5.8% so far in response to what many analysts have seen as a surprisingly conservative outlook given by the management at the Annual JPMorgan Virtual Healthcare Conference today.Instead of giving the 2021 guidance, the management has described the year as ...
In 2020, I generated total returns of 24.17%. My dividend income increased by 10.78%, year-over-year. 2020 marked another year of outperformance for me (I've now beaten the S&P 500 during 7 out of the last 9 years). For further details see: Nicholas Ward's Dividend G...
I received shares in Viatris following the spin-off from Pfizer. The company will only start paying a dividend next year. I don't like being a shareholder by default, so I decided to analyze the company and see whether it's a decent investment. For further details see: I...
Growing your dividend income takes time and consistency. In December, we (my wife and I) received a total of $5,483.32 of dividend income. I received only 3 dividend increases in December. No big surprises here, but very solid increases. For further details see: Dividend...
In 2015, I started publishing quarterly updates regarding my dividend growth portfolio. I believe that someone who writes about financial assets should share his main holdings with his readers. In this article, I will share my portfolio, changes in the past 3 months and stocks tha...
This real-money portfolio was first introduced to the Seeking Alpha community in December 2015. The portfolio outperformed its benchmark in Q4 2020 and is now outperforming the S&P 500's performance since late-2015. The portfolio was overweight Financials and Industrials headi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...